Trachyonychia (from Greek trachys 'rough' and onyx 'nail') is a clinical descriptive term for a nail disorder characterized by rough, opaque, longitudinally ridged nails with a sandpaper-like appearance, or alternatively shiny pitted nails with retained luster. The condition was originally described by Alkiewicz in 1950, and the term twenty-nail dystrophy (TND) was coined by Hazelrigg in 1977 to describe idiopathic involvement of all 20 nails (fingernails and toenails) in children. Subsequent reports clarified that the same morphology can occur in association with various dermatologic conditions, with associations identified in 12-46% of cases (most commonly alopecia areata, then lichen planus, psoriasis, atopic dermatitis, eczema, and ichthyosis vulgaris). Two clinical morphologic forms are recognized: (1) Opaque trachyonychia (more common, traditional 'sandpaper nails'): rough surface with longitudinal ridging, loss of luster, opacity, increased fragility, and brittle nails. (2) Shiny trachyonychia: excessive small punctate pits with retention of nail luster, less commonly described but also characteristic. Some authors describe a third pattern with increased longitudinal ridging without sandpaper appearance.
Demographics and clinical presentation: trachyonychia is most common in children (ages 3-12), with marked male predominance (3:1 in pediatric series). Adult onset can occur, often more persistent. Pediatric trachyonychia frequently presents as twenty-nail dystrophy (all 20 nails involved), but partial involvement of fewer nails is also common. Adult trachyonychia more often involves selected nails. Onset is gradual, with parents or patient noticing rough texture and dull appearance of nails. The nail plate is rough, opaque, gray-brown, with fine longitudinal ridging visible as parallel lines. The plate is often thinned and brittle, prone to splitting and chipping at the free edge. Punctate pitting may be present (especially in shiny variant). Nail growth rate may be slow. The nail bed is normal (no onycholysis or oil drop sign as in psoriasis). Periungual skin and cuticles are usually normal. Examination of associated conditions: scalp examination for alopecia areata patches (most common association), skin examination for lichen planus violaceous papules with Wickham striae, psoriasis plaques, atopic dermatitis flexural eczema, ichthyosis vulgaris diffuse fine scaling. Differential diagnosis: nail psoriasis (oil drop sign, onycholysis, salmon patch, large irregular pits), nail lichen planus (pterygium, longitudinal melanonychia, splinter hemorrhages, more severe involvement), alopecia areata-related nail changes (regular fine pits in geometric pattern), nail eczema (peri-ungual erythema, paronychia), drug-induced nail dystrophy, traumatic nail dystrophy, and onychomycosis (fungal — KOH or culture if uncertain).
Diagnosis is clinical based on characteristic appearance. Workup: detailed history of nail changes, family history (alopecia areata, psoriasis, atopic dermatitis), associated symptoms (hair loss, joint pain, skin rashes), drug history. Physical examination of all 20 nails, scalp, and skin for associated dermatoses. Dermoscopy may show longitudinal ridging and pitting better. Nail biopsy is rarely needed but can be performed for atypical cases — most commonly shows inflammatory changes consistent with the associated dermatosis (psoriasiform, lichenoid, or spongiotic patterns). Twenty-nail dystrophy with isolated trachyonychia and no associated condition is considered idiopathic, but most authors believe this represents a variant or 'forme fruste' of an underlying inflammatory dermatosis (lichen planus or alopecia areata). Course and prognosis: pediatric trachyonychia usually has favorable prognosis with spontaneous improvement over months to years (median 6 years in some series), with majority resolving by adolescence. Adult trachyonychia may be more persistent and slow to resolve. Permanent nail damage from scarring (pterygium) is rare in trachyonychia (more common in nail lichen planus). Treatment: as the condition is generally benign and often self-limited in children, treatment is conservative and primarily aimed at improving cosmesis: (1) Nail moisturizers and emollients (urea, lactic acid, biotin-containing creams) to improve nail hydration and reduce splitting. (2) Biotin supplementation 5-10 mg/day for 6-12 months may improve nail strength (limited evidence). (3) Avoiding nail trauma, picking, and harsh chemicals. (4) Nail polish with hardeners can mask appearance and protect the nail. (5) Topical corticosteroids (clobetasol, betamethasone) under occlusion or with intralesional triamcinolone (5-10 mg/mL) injections to nail matrix for limited or recalcitrant cases — risk of skin atrophy and HPA axis suppression with prolonged use. (6) Topical tacrolimus or pimecrolimus as steroid-sparing alternatives. (7) Treatment of associated dermatoses (alopecia areata, lichen planus, psoriasis) with appropriate therapies often improves nail involvement. (8) Systemic treatments (oral steroids, methotrexate, cyclosporine, biologics) reserved for severe disabling cases or as part of treatment for severe associated dermatosis. Patient and parent education on benign nature, expected slow improvement, and cosmetic interventions is important. Reassurance is often most important component of management.